New Protections on Pharmaceutical Data Drafted by China
Seeking to encourage drug companies to conduct more clinical trials of innovative medicines in China, the Chinese government has proposed new protections on pharmaceutical data. Under the draft proposal, the China Drug Administration (CDA) would expand data exclusivity—the protection of clinical data... Read More